Cargando…
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
Triple-negative breast cancers (TNBCs) are more likely to occur in younger patients and have a poor prognosis. They are highly heterogeneous tumors consisting of different molecular subtypes. The only common characteristic among them is the absence of targets for endocrine therapy and human epiderma...
Autor principal: | Carvalho, Filomena Marino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666917/ https://www.ncbi.nlm.nih.gov/pubmed/38023167 http://dx.doi.org/10.3389/fonc.2023.1244781 |
Ejemplares similares
-
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021) -
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022) -
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
por: Neophytou, Christiana, et al.
Publicado: (2018) -
Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
por: Mast, Jesse M., et al.
Publicado: (2018) -
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
por: Srivastava, Nityanand, et al.
Publicado: (2023)